Changes in retinal structural thickness after Lecanemab in Alzheimer's Disease
Lecanemab reduced markers of amyloid in early AD and resulted in significant thickening of the RNFL (axonal structure of the retina) and thickening of the RGC (neuronal structural associated with visual function in the retina. Longer trials are warranted to determine the efficacy and safety of lecanemab in eye of early AD patients.
Authors
- Zhiming Pan
- Zhen Wang
Institutions
- Wenzhou Medical University (CN)
- First Affiliated Hospital of Wenzhou Medical University (CN)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_101736
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00